MPH Health Care AG (DB: 93M1)
Health Care · Pharmaceuticals · DE
€23.30
-1.27% today · +37.5% 1Y
MPH Health Care AG (DB: 93M1) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $116.46M.
Over the last twelve months the share price has gained 37.5%, trading between 16.80 and 29.70.
Tweenvest scores MPH Health Care AG across four factors: quality 51/100, value 71/100, growth 96/100, dividend 90/100. Its strongest factor is growth.
93M1 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $116.46M
- Revenue (TTM)
- $58.85M
- P/E
- —
- EPS
- -6.85
- Dividend yield
- 21.46%
- Beta (5Y)
- 1.10
- 52-week high
- €29.70
- 52-week low
- €16.80
- Avg volume (3M)
- —
- Shares outstanding
- 4.28M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,178.86 | -0.89% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $267.13 | -1.06% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $151.54 | -1.02% |
| Roche Holding AGSWX: ROP | $365.10B | CHF363.80 | -1.22% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £121.44 | -0.74% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.07 | -0.81% |
Figures last refreshed Aug 18, 2026.